Cargando…

Is N-acetyl-d-glucosamine a rigid (4)C(1) chair?

Understanding microsecond-timescale dynamics is crucial to establish three-dimensional (3D) structure–activity relationships in sugars but has been intractable to experiments and simulations. As a consequence, whether arguably the most important chemical scaffold in glycobiology, N-acetyl-d-glucosam...

Descripción completa

Detalles Bibliográficos
Autores principales: Sattelle, Benedict M, Almond, Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3219419/
https://www.ncbi.nlm.nih.gov/pubmed/21807769
http://dx.doi.org/10.1093/glycob/cwr101
_version_ 1782216839959412736
author Sattelle, Benedict M
Almond, Andrew
author_facet Sattelle, Benedict M
Almond, Andrew
author_sort Sattelle, Benedict M
collection PubMed
description Understanding microsecond-timescale dynamics is crucial to establish three-dimensional (3D) structure–activity relationships in sugars but has been intractable to experiments and simulations. As a consequence, whether arguably the most important chemical scaffold in glycobiology, N-acetyl-d-glucosamine (GlcNAc), deviates from a rigid (4)C(1) chair is unknown. Here, conformer populations and exchange kinetics were quantified from the longest aqueous carbohydrate simulations to date (0.2 ms total) of GlcNAc, four derivatives from heparan sulfate and their methylglycosides. Unmodified GlcNAc took 3–5 μs to reach a conformational equilibrium, which comprised a metastable (4)C(1) chair that underwent (4)C(1) ↔ (1)C(4) transitions at a predicted forward rate of 0.8 μs(−1) with an average (1)C(4)-chair lifetime of 3 ns. These predictions agree with high-resolution crystallography and nuclear magnetic resonance but not with the hypothesis that GlcNAc is a rigid (4)C(1) chair, concluded from previous experimental analyses and non-aqueous modeling. The methylglycoside was calculated to have a slower forward rate (0.3 μs(−1)) and a more stable (4)C(1) conformer (0.2 kcal mol(−1)), suggesting that pivotal 3D intermediates (particularly (2)S(O), (1)S(5) and B(2,5)) increased in energy, and water was implicated as a major cause. Sulfonation (N-, 3-O and 6-O) significantly augmented this effect by blocking pseudorotation, but did not alter the rotational preferences of hydroyxl or hydroxymethyl groups. We therefore propose that GlcNAc undergoes puckering exchange that is dependent on polymerization and sulfo substituents. Our analyses, and 3D model of the equilibrium GlcNAc conformer in water, can be used as dictionary data and present new opportunities to rationally modify puckering and carbohydrate bioactivity, with diverse applications from improving crop yields to disease amelioration.
format Online
Article
Text
id pubmed-3219419
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-32194192011-11-18 Is N-acetyl-d-glucosamine a rigid (4)C(1) chair? Sattelle, Benedict M Almond, Andrew Glycobiology Original Articles Understanding microsecond-timescale dynamics is crucial to establish three-dimensional (3D) structure–activity relationships in sugars but has been intractable to experiments and simulations. As a consequence, whether arguably the most important chemical scaffold in glycobiology, N-acetyl-d-glucosamine (GlcNAc), deviates from a rigid (4)C(1) chair is unknown. Here, conformer populations and exchange kinetics were quantified from the longest aqueous carbohydrate simulations to date (0.2 ms total) of GlcNAc, four derivatives from heparan sulfate and their methylglycosides. Unmodified GlcNAc took 3–5 μs to reach a conformational equilibrium, which comprised a metastable (4)C(1) chair that underwent (4)C(1) ↔ (1)C(4) transitions at a predicted forward rate of 0.8 μs(−1) with an average (1)C(4)-chair lifetime of 3 ns. These predictions agree with high-resolution crystallography and nuclear magnetic resonance but not with the hypothesis that GlcNAc is a rigid (4)C(1) chair, concluded from previous experimental analyses and non-aqueous modeling. The methylglycoside was calculated to have a slower forward rate (0.3 μs(−1)) and a more stable (4)C(1) conformer (0.2 kcal mol(−1)), suggesting that pivotal 3D intermediates (particularly (2)S(O), (1)S(5) and B(2,5)) increased in energy, and water was implicated as a major cause. Sulfonation (N-, 3-O and 6-O) significantly augmented this effect by blocking pseudorotation, but did not alter the rotational preferences of hydroyxl or hydroxymethyl groups. We therefore propose that GlcNAc undergoes puckering exchange that is dependent on polymerization and sulfo substituents. Our analyses, and 3D model of the equilibrium GlcNAc conformer in water, can be used as dictionary data and present new opportunities to rationally modify puckering and carbohydrate bioactivity, with diverse applications from improving crop yields to disease amelioration. Oxford University Press 2011-12 2011-08-01 /pmc/articles/PMC3219419/ /pubmed/21807769 http://dx.doi.org/10.1093/glycob/cwr101 Text en © 2011 The Author(s). Published by Oxford University Press. All rights reserved. http://creativecommons.org/licenses/by-nc/2.5/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.5), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited
spellingShingle Original Articles
Sattelle, Benedict M
Almond, Andrew
Is N-acetyl-d-glucosamine a rigid (4)C(1) chair?
title Is N-acetyl-d-glucosamine a rigid (4)C(1) chair?
title_full Is N-acetyl-d-glucosamine a rigid (4)C(1) chair?
title_fullStr Is N-acetyl-d-glucosamine a rigid (4)C(1) chair?
title_full_unstemmed Is N-acetyl-d-glucosamine a rigid (4)C(1) chair?
title_short Is N-acetyl-d-glucosamine a rigid (4)C(1) chair?
title_sort is n-acetyl-d-glucosamine a rigid (4)c(1) chair?
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3219419/
https://www.ncbi.nlm.nih.gov/pubmed/21807769
http://dx.doi.org/10.1093/glycob/cwr101
work_keys_str_mv AT sattellebenedictm isnacetyldglucosaminearigid4c1chair
AT almondandrew isnacetyldglucosaminearigid4c1chair